Adeera Levin

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 32

Top Topics

Chronic Kidney Disease

Monoclonal Antibody

Top Venues

Nature medicine

Nature reviews. Nephrology

Diabetes, obesity & metabolism

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Adeera Levin
Overcoming barriers to deliver high quality kidney care. Nature reviews. Nephrology 20 (3) (2024)
Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, Vivekananda Jha, Carol A Pollock, Katherine R Tuttle, Peter Kotanko, Andrzej Wiecek, Hans Joachim Anders, Guiseppe Remuzzi, Kamyar Kalantar-Zadeh, Adeera Levin, Raymond C Vanholder
A new era in the science and care of kidney diseases. Nature reviews. Nephrology 20 (7) (2024)
Sarah E Bota, Eric McArthur, Kyla L Naylor, Peter G Blake, Kevin Yau, Michelle A Hladunewich, Adeera Levin, Matthew J Oliver
Long-Term Morbidity and Mortality of Coronavirus Disease 2019 in Patients Receiving Maintenance Dialysis: A Multicenter Population-Based Cohort Study. Kidney360 5 (8) (2024)
Adeera Levin
Overcoming barriers to deliver high quality kidney care. Nature reviews. Nephrology (2024)
Kathryn Cardoza, Amy Kang, Brendan Smyth, Tae Won Yi, Carol Pollock, Rajiv Agarwal, George Bakris, David M Charytan, Dick de Zeeuw, David C Wheeler, Hong Zhang, Christopher P Cannon, Vlado Perkovic, Clare Arnott, Adeera Levin, Kenneth W Mahaffey
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial. Diabetes, obesity & metabolism 26 (9) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine 30 (8) (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine 30 (8) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine 30 (8) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Sarah E Bota, Eric McArthur, Kyla L Naylor, Peter G Blake, Kevin Yau, Michelle A Hladunewich, Adeera Levin, Matthew J Oliver
Long-Term Morbidity and Mortality of COVID-19 in Patients Receiving Maintenance Dialysis: A Multi-Center Population-Based Cohort Study. Kidney360 (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, Vivekananda Jha, Carol A Pollock, Katherine R Tuttle, Peter Kotanko, Andrzej Wiecek, Hans Joachim Anders, Guiseppe Remuzzi, Kamyar Kalantar-Zadeh, Adeera Levin, Raymond C Vanholder
A new era in the science and care of kidney diseases. Nature reviews. Nephrology (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
Author Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Adeera Levin
Overcoming barriers to deliver high quality kidney care. Nature reviews. Nephrology 20 (3) (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association (2024)
Kathryn Cardoza, Amy Kang, Brendan Smyth, Tae Won Yi, Carol Pollock, Rajiv Agarwal, George Bakris, David M Charytan, Dick de Zeeuw, David C Wheeler, Hong Zhang, Christopher P Cannon, Vlado Perkovic, Clare Arnott, Adeera Levin, Kenneth W Mahaffey
Geographic and racial variability in kidney, cardiovascular and safety outcomes with canagliflozin: A secondary analysis of the CREDENCE randomized trial. Diabetes, obesity & metabolism (2024)
Adeera Levin
Overcoming barriers to deliver high quality kidney care. Nature reviews. Nephrology 20 (3) (2024)
Tariq Jamal Siddiqi, David Cherney, Hasan Fareed Siddiqui, Tazeen Hasan Jafar, James L Januzzi, Muhammad Shahzeb Khan, Adeera Levin, Nikolaus Marx, Janani Rangaswami, Jeffrey Testani, Muhammad Shariq Usman, Christoph Wanner, Faiez Zannad, Javed Butler
Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Kidney Outcomes across Baseline Cardiovascular-Kidney-Metabolic Conditions: A Systematic Review and Meta-Analyses. Journal of the American Society of Nephrology : JASN (2024)
Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S Bajaj, G B John Mancini, Norman C Wong, April E Hebert, Fernando G Ang, Wally Rapattoni, Brendon L Neuen, Clare Arnott, Vlado Perkovic, Kenneth W Mahaffey
Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial. Journal of the American Heart Association 13 (3) (2024)
Glenn M Chertow, Anna Marie Chang, G Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström, David M Charytan, Regina Clementi, Charles Michael Gibson, Shaun G Goodman, Meg Jardine, Adeera Levin, Yuliya Lokhnygina, Jenny Mears, Roxana Mehran, Stenvinkel Peter, Angela Yee-Moon Wang, David C Wheeler, Carmine Zoccali, Paul M Ridker, Kenneth W Mahaffey, Pierluigi Tricoci, Myles Wolf
IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial. Nature medicine (2024)
Carmine Zoccali, Francesca Mallamaci, Liz Lightstone, Vivekananda Jha, Carol A Pollock, Katherine R Tuttle, Peter Kotanko, Andrzej Wiecek, Hans Joachim Anders, Guiseppe Remuzzi, Kamyar Kalantar-Zadeh, Adeera Levin, Raymond C Vanholder
A new era in the science and care of kidney diseases. Nature reviews. Nephrology 20 (7) (2024)
Sarah E Bota, Eric McArthur, Kyla L Naylor, Peter G Blake, Kevin Yau, Michelle A Hladunewich, Adeera Levin, Matthew J Oliver
Long-Term Morbidity and Mortality of Coronavirus Disease 2019 in Patients Receiving Maintenance Dialysis: A Multicenter Population-Based Cohort Study. Kidney360 5 (8) (2024)
Tae Won Yi, Michelle M Y Wong, Brendon L Neuen, Clare Arnott, Paul Poirier, Jochen Seufert, April Slee, Wally Rapattoni, Fernando G Ang, David C Wheeler, Kenneth W Mahaffey, Vlado Perkovic, Adeera Levin
Effects of canagliflozin on cardiovascular and kidney events in patients with chronic kidney disease with and without peripheral arterial disease: integrated analysis from the CANVAS Program and CREDENCE trial. Diabetes, obesity & metabolism (2023)
Adeera Levin
Predicting Outcomes in Nephrology: Lots of Tools, Limited Uptake: How Do We Move Forward? Journal of the American Society of Nephrology : JASN (2023)
Abhinav Sharma, Pedro Marques, Brendon L Neuen, Robert A Fletcher, April E Hebert, Wally Rapattoni, Fernando G Ang, Clare Arnott, Adeera Levin, Subodh Verma, Vlado Perkovic, Kenneth W Mahaffey
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: Insights from the CANVAS Program and CREDENCE trial. Diabetes, obesity & metabolism (2023)
Amy Kang, Brendan Smyth, Brendon L Neuen, Hiddo J Lambers Heerspink, Gian Luca Di Tanna, Hong Zhang, Clare Arnott, Carinna Hockham, Rajiv Agarwal, George L Bakris, David M Charytan, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, David C Wheeler, Kenneth W Mahaffey, Vlado Perkovic, Meg J Jardine
The sodium-glucose cotransporter-2 inhibitor canagliflozin does not increase risk of non-genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double-blind trials. Diabetes, obesity & metabolism (2023)
Vikas S Sridhar, Brendon L Neuen, Robert A Fletcher, April Slee, Fernando G Ang, Wally Rapattoni, Clare Arnott, David Z I Cherney, Vlado Perkovic, David C Wheeler, Adeera Levin
Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials. Diabetes, obesity & metabolism (2023)
David R W Jayne, Michael Walsh, Peter A Merkel, Chen Au Peh, Wladimir M Szpirt, Xavier Puechal, Shouichi Fujimoto, Carmel M Hawley, Nader A Khalidi, Rachel Jones, Oliver Flossmann, Ron Wald, Louis-Philippe Girard, Adeera Levin, Gina Gregorini, Lorraine Harper, William Clark, Christian Pagnoux, Ulrich Specks, Lucy Smyth, Toshiko Ito-Ihara, Janak R de Zoysa, Biljana Brezina, Andrea Mazzetti, Carol A McAlear, Donna Reidlinger, Samir Mehta, Natalie J Ives, Elizabeth A Brettell, Hugh Jarrett, Keith Wheatley, Elizabeth Broadhurst, Alina Casian, Charles D Pusey
Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT. Health technology assessment (Winchester, England) 26 (38) (2022)